Research led by scientists at Queen Mary University of London is heralding in a new era for genetic sequencing and testing.
MediLink and Roche partner on cancer drug development
Share this article Roche will gain sole international rights to develop, produce and market YL211. Credit: Marlon Trottmann / Shutterstock.com. MediLink Therapeutics has signed a